Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The American Journal of Gastroenterology|October 24, 2003
A prospective study of the clinical, genetic, screening, and pathologic features of a family with hereditary mixed polyposis syndromeP Rozen, Z Samuel, E Brazowski
Lupus|October 31, 1998
Rheumatoid nodules in a patient with primary antiphospholipid (Hughes) syndromeO Elkayam, M Yaron, E Brazowski, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 28, 2004
Extramammary Paget's disease of the perianal regionH Tulchinsky, O Zmora, E Brazowski, et al.
Clinical and Translational Gastroenterology|October 8, 2020
Determinants of Pouch-Related Symptoms, a Common Outcome of Patients With Adenomatous Polyposis Undergoing Ileoanal Pouch SurgeryOphir Gilad, N Gluck, E Brazowski, et al.
Human Reproduction (Oxford, England)|July 1, 1996
Mucocele formation 20 years after an appendiceal uterine transplantation for infertility mistaken for hydrops tubae profluensD Grisaru, J B Lessing, E Brazowski, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2001
Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in ratsI Dotan, R Hershkoviz, F Karmeli, et al.
Digestion|March 30, 1999
Continuous intravenous octreotide treatment for acute experimental pancreatitisR Greenberg, R Haddad, H Kashtan, et al.
Digestive Diseases and Sciences|November 25, 2003
Rofecoxib reduces polyp recurrence in familial polyposisA Hallak, L Alon-Baron, R Shamir, et al.
Inflammatory Bowel Diseases|March 12, 2010
CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in miceN Maharshak, G Hart, E Ron, et al.
Digestive Diseases and Sciences|October 30, 2001
Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trialI Dotan, A Hallak, N Arber, et al.
Pageof 2